210 related articles for article (PubMed ID: 25879290)
1. Hepatitis regulation by the inflammasome signaling pathway.
Negash AA; Gale M
Immunol Rev; 2015 May; 265(1):143-55. PubMed ID: 25879290
[TBL] [Abstract][Full Text] [Related]
2. Caspase-1: the inflammasome and beyond.
Sollberger G; Strittmatter GE; Garstkiewicz M; Sand J; Beer HD
Innate Immun; 2014 Feb; 20(2):115-25. PubMed ID: 23676582
[TBL] [Abstract][Full Text] [Related]
3. The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications.
Osawa R; Williams KL; Singh N
J Infect; 2011 Feb; 62(2):119-29. PubMed ID: 20950647
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of the inflammasome: keeping inflammation under control.
Pedraza-Alva G; Pérez-Martínez L; Valdez-Hernández L; Meza-Sosa KF; Ando-Kuri M
Immunol Rev; 2015 May; 265(1):231-57. PubMed ID: 25879297
[TBL] [Abstract][Full Text] [Related]
5. Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.
Wilson NS; Duewell P; Yang B; Li Y; Marsters S; Koernig S; Latz E; Maraskovsky E; Morelli AB; Schnurr M; Ashkenazi A
J Immunol; 2014 Apr; 192(7):3259-68. PubMed ID: 24610009
[TBL] [Abstract][Full Text] [Related]
6. Inflammasome: A Double-Edged Sword in Liver Diseases.
Luan J; Ju D
Front Immunol; 2018; 9():2201. PubMed ID: 30319645
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens.
Zannetti C; Roblot G; Charrier E; Ainouze M; Tout I; Briat F; Isorce N; Faure-Dupuy S; Michelet M; Marotel M; Kati S; Schulz TF; Rivoire M; Traverse-Glehen A; Luangsay S; Alatiff O; Henry T; Walzer T; Durantel D; Hasan U
J Immunol; 2016 Jul; 197(1):356-67. PubMed ID: 27226092
[TBL] [Abstract][Full Text] [Related]
8. The innate immune response during liver inflammation and metabolic disease.
Bieghs V; Trautwein C
Trends Immunol; 2013 Sep; 34(9):446-52. PubMed ID: 23668977
[TBL] [Abstract][Full Text] [Related]
9. Activation and regulation of the inflammasomes.
Latz E; Xiao TS; Stutz A
Nat Rev Immunol; 2013 Jun; 13(6):397-411. PubMed ID: 23702978
[TBL] [Abstract][Full Text] [Related]
10. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1.
Keyel PA
Cytokine; 2014 Sep; 69(1):136-45. PubMed ID: 24746243
[TBL] [Abstract][Full Text] [Related]
11. Deregulated inflammasome signaling in disease.
Lamkanfi M; Vande Walle L; Kanneganti TD
Immunol Rev; 2011 Sep; 243(1):163-73. PubMed ID: 21884175
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta processing in host defense: beyond the inflammasomes.
Netea MG; Simon A; van de Veerdonk F; Kullberg BJ; Van der Meer JW; Joosten LA
PLoS Pathog; 2010 Feb; 6(2):e1000661. PubMed ID: 20195505
[TBL] [Abstract][Full Text] [Related]
13. [The inflammasomes: platforms of innate immunity].
Jamilloux Y; Henry T
Med Sci (Paris); 2013 Nov; 29(11):975-84. PubMed ID: 24280500
[TBL] [Abstract][Full Text] [Related]
14. Microcrystals as DAMPs and their role in joint inflammation.
Busso N; So A
Rheumatology (Oxford); 2012 Jul; 51(7):1154-60. PubMed ID: 22332122
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta (IL-1beta) processing pathway.
Weber A; Wasiliew P; Kracht M
Sci Signal; 2010 Jan; 3(105):cm2. PubMed ID: 20086236
[TBL] [Abstract][Full Text] [Related]
16. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
[TBL] [Abstract][Full Text] [Related]
17. Human hepatocytes express absent in melanoma 2 and respond to hepatitis B virus with interleukin-18 expression.
Pan X; Xu H; Zheng C; Li M; Zou X; Cao H; Xu Q
Virus Genes; 2016 Aug; 52(4):445-52. PubMed ID: 27094165
[TBL] [Abstract][Full Text] [Related]
18. Inflammasome-independent regulation of IL-1-family cytokines.
Netea MG; van de Veerdonk FL; van der Meer JW; Dinarello CA; Joosten LA
Annu Rev Immunol; 2015; 33():49-77. PubMed ID: 25493334
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
[TBL] [Abstract][Full Text] [Related]
20. The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge.
Chen KW; Groß CJ; Sotomayor FV; Stacey KJ; Tschopp J; Sweet MJ; Schroder K
Cell Rep; 2014 Jul; 8(2):570-82. PubMed ID: 25043180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
